- Previous Close
0.0030 - Open
0.0020 - Bid 0.0020 x --
- Ask 0.0030 x --
- Day's Range
0.0020 - 0.0030 - 52 Week Range
0.0010 - 0.0080 - Volume
436,300 - Avg. Volume
4,443,191 - Market Cap (intraday)
10.104M - Beta (5Y Monthly) 0.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia. The company offers its services through ProEX, a clinical virtual care software; Vision Telehealth Platform; and VF Sync software which develops to connect multiple ProEX Telehealth Hub. It also provides virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves aged care, rural health, remote health, general practice, indigenous healthcare, In-home care, oil, gas, and mining, merchant navy, armed forces, and corrections sectors. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.
www.vfx-group.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: VFX.AX
View MorePerformance Overview: VFX.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VFX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VFX.AX
View MoreValuation Measures
Market Cap
10.10M
Enterprise Value
9.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.64
Price/Book (mrq)
--
Enterprise Value/Revenue
1.45
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-50.69%
Return on Assets (ttm)
-47.54%
Return on Equity (ttm)
--
Revenue (ttm)
5.6M
Net Income Avi to Common (ttm)
-2.69M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.43M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.71M